Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAG | P20916 | 2/20 | 0.52 |
| ▸ | NANP | Q8TBE9 | 3/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | SIGLEC7 | Q9Y286 | 1/20 | 0.46 |
| ▸ | CD22 | P20273 | 3/20 | 0.44 |
| ▸ | NEU4 | Q8WWR8 | 2/20 | 0.42 |
| ▸ | NEU3 | Q9UQ49 | 2/20 | 0.42 |
| ▸ | NEU2 | Q9Y3R4 | 2/20 | 0.42 |
| ▸ | NEU1 | Q99519 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30481193 | 1.00 | MAG (0.52) | MAGNANPL3MBTL1SIGLEC7CD22 | |
| SCHEMBL14229129 | 1.00 | MAG (0.52) | MAGNANPL3MBTL1SIGLEC7CD22 | |
| SCHEMBL25702221 | 1.00 | MAG (0.52) | MAGNANPL3MBTL1SIGLEC7CD22 | |
| SCHEMBL27977966 | 1.00 | MAG (0.52) | MAGNANPL3MBTL1SIGLEC7CD22 | |
| SCHEMBL14946228 | 1.00 | MAG (0.52) | MAGNANPL3MBTL1SIGLEC7CD22 | |
| SCHEMBL31500844 | 1.00 | MAG (0.52) | MAGNANPL3MBTL1SIGLEC7CD22 | |
| SCHEMBL14944652 | 0.85 | L3MBTL1 (0.47) | MAGL3MBTL1CD22 | |
| SCHEMBL10339608 | 0.85 | NANP (0.58) | MAGNANPL3MBTL1SIGLEC7NEU4 | |
| SCHEMBL14902867 | 0.84 | NANP (0.44) | MAGNANP | |
| SCHEMBL8377625 | 0.84 | NANP (0.58) | MAGNANPL3MBTL1SIGLEC7NEU4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7985731-B2 | Sugar chain added GLP-1 peptide | OTSUKA CHEMICAL HOLDINGS CO., LTD. (JP) | 2011-07-26 | — | — | US | disclosed |
| US-20090111739-A1 | SUGAR CHAIN ADDED GLP-1 PEPTIDE | OTSUKA CHEMICAL CO., LTD. (JP) | 2009-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090111739-A1 | SUGAR CHAIN ADDED GLP-1 PEPTIDE | GLP1R, IAPP, GIPR | MAG 1836/4885NANP 1583/4885L3MBTL1 503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.